INFLUENZA, HUMAN
Clinical trials for INFLUENZA, HUMAN explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA, HUMAN trials appear
Sign up with your email to follow new studies for INFLUENZA, HUMAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA flu shots enter human testing – could they beat the old ones?
Prevention OngoingThis study tests several new mRNA-based flu vaccines in about 971 healthy adults aged 18 and older. The goal is to see how well they trigger an immune response and how safe they are compared to standard flu shots. Participants receive one dose of an experimental vaccine or a comp…
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Prevention
Last updated Jun 27, 2026 12:01 UTC
-
Pharmacy letters could boost vaccination and cut stroke risk
Prevention OngoingThis study tests whether sending a short, encouraging letter from a pharmacist can motivate more adults to get their flu and travel vaccines. Researchers will track vaccination rates and also check if vaccinated people have fewer strokes in the following six months. About 20,000 …
Matched conditions: INFLUENZA, HUMAN
Phase: NA • Sponsor: University of Calgary • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC
-
Nasal spray vs. needle: which flu vaccine works better?
Knowledge-focused OngoingThis study compares two flu vaccines: a nasal spray and a standard shot. Researchers will measure immune responses in the nose and blood of 60 healthy adults aged 18-49. The goal is to understand how each vaccine triggers protection and find ways to improve future flu vaccines.
Matched conditions: INFLUENZA, HUMAN
Phase: EARLY_PHASE1 • Sponsor: Copenhagen Respiratory Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC